CLDN14 and nephrolithiasis: More specifically, their aim was to quantitatively assess promoter methylation in three genes that are frequently identified in recurrent kidney stone formers and whose expression patterns are controlled by promoter methylation: vitamin D receptor (VDR), calcium-sensing receptor (CaSR), and claudin 14 (CLDN14).